Barriers and facilitators to dispensing of intranasal naloxone by pharmacists

References

• United Nations Office on Drugs and Crime. World Drug Report. https://www.unodc.org/documents/data-and-analysis/WDR2014/World_Drug_Report_2014_web.pdf. Published 2014. Accessed September 1, 2017.
   Google Scholar
• Deyo RA, Von Korff M, Duhrkoop D. Opioids for low back pain. BMJ. 2015;350:g6380. doi: 10.1136/bmj.g6380. PMID: 25561513
   PubMed Web of Science ®Google Scholar
• Rudd RA, Seth P, David F, Scholl L. Increases in drug and opioid-involved overdose deaths—United States, 2010–2015. MMWR Morb Mortal Wkly Rep. 2016;65:1445–1452. PMID: 28033313
   PubMed Web of Science ®Google Scholar
• Kim HK, Nelson LS. Reducing the harm of opioid overdose with the safe use of naloxone: a pharmacologic review. Expert Opin Drug Saf. 2015;14:1137–1146. doi: 10.1517/14740338.2015.1037274. PMID: 25865597
   PubMed Web of Science ®Google Scholar
• Mueller SR, Walley AY, Calcaterra SL, Glanz JM, Binswanger IA. A review of opioid overdose prevention and naloxone prescribing: implications for translating community programming into clinical practice. Subst Abus. 2015;36:240–253. doi: 10.1080/08897077.2015.1010032. PMID: 25774771
   PubMed Web of Science ®Google Scholar
• Alhabib S, Aldraimly M, Alfarhan A. An evolving role of clinical pharmacists in managing diabetes: evidence from the literature. Saudi Pharm J. 2016;24:441–446. doi: 10.1016/j.jsps.2014.07.008. PMID: 27330374
   PubMed Web of Science ®Google Scholar
• Isenor JE, Edwards NT, Alia TA, et al. Impact of pharmacists as immunizers on vaccination rates: a systematic review and meta-analysis. Vaccine. 2016;34:5708–5723. doi: 10.1016/j.vaccine.2016.08.085. PMID: 27765379
   PubMed Web of Science ®Google Scholar
• Dent LA, Harris KJ, Noonan CW. Tobacco interventions delivered by pharmacists: a summary and systematic review. Pharmacotherapy. 2007;27:1040–1051. doi: 10.1592/phco.27.7.1040. PMID:17594210
   PubMed Web of Science ®Google Scholar
• Adams AJ, Weaver KK. The continuum of pharmacist prescriptive authority. Ann Pharmacother. 2016;50:778–784. doi: 10.1177/1060028016653608. PMID:27307413
   PubMed Web of Science ®Google Scholar
• Bailey AM, Wermeling DP. Naloxone for opioid overdose prevention: pharmacists' role in community-based practice settings. Ann Pharmacother. 2014;48:601–606. doi: 10.1177/1060028014523730. PMID:24523396
   PubMed Web of Science ®Google Scholar
• Regulation and Licensing Department—Board of Pharmacy, Albuquerque, NM. Occupational and Professional Licensing. Statutory Authority. Pharmacist Prescriptive Authority Naloxone Protocol. 16.19.26.13. http://164.64.110.239/nmac/parts/title16/16.019.0026.htm. Published 2014. Accessed June 6, 2016.
   Google Scholar
• Landen M. Naloxone Statewide Standing Order. Senate Bill 262/House Bill 277, 2016. https://nmhealth.org/publication/view/regulation/2126/. Accessed June 6, 2016.
   Google Scholar
• Morton KJ, Harrand B, Floyd CC, et al. Pharmacy-based statewide naloxone distribution: a novel “top-down, bottom-up” approach. J Am Pharm Assoc. 2017;57(2 Suppl):S99–S106.e105. doi: 10.1016/j.japh.2017.01.017.
   Google Scholar
• Bachyrycz A, Shrestha S, Bleske BE, Tinker D, Bakhireva LN. Opioid overdose prevention through pharmacy-based naloxone prescription program: innovations in health care delivery. Subst Abus. 2017;38:55–60. doi: 10.1080/08897077.2016.1184739. PMID:27164192
   PubMed Web of Science ®Google Scholar
• Freeman PR, Goodin A, Troske S, Strahl A, Fallin A, Green TC. Pharmacists' role in opioid overdose: Kentucky pharmacists' willingness to participate in naloxone dispensing. J Am Pharm Assoc. 2017;57(2 Suppl):S28–S33. doi: 10.1016/j.japh.2016.12.064.
   Google Scholar
• Green TC, Case P, Fiske H, et al. Perpetuating stigma or reducing risk? Perspectives from naloxone consumers and pharmacists on pharmacy-based naloxone in 2 states. J Am Pharm Assoc. 2017;57(2 Suppl):S19–S27.e14. doi: 10.1016/j.japh.2017.01.013.
   Google Scholar
• Thornton JD, Lyvers E, Scott VG, Dwibedi N. Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia. J Am Pharm Assoc. 2017;57(2 Suppl):S12–S18.e14. doi: 10.1016/j.japh.2016.12.070.
   Google Scholar
• Rosenstock IM, Strecher VJ, Becker MH. Social learning theory and the health belief model. Health Educ Q. 1988;15:175–183. doi: 10.1177/109019818801500203. PMID:3378902
   PubMedGoogle Scholar
• Creswell JW. Research Design: Qualitative, Quantitative, and Mixed Methods Approaches. Thousand Oaks, CA: Sage publications; 2013.
   Google Scholar
• NVivo qualitative data analysis software [computer program]. Version 11. Melbourne, Australia: QSR International; 2015.
   Google Scholar
• Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77–101. doi: 10.1191/1478088706qp063oa.
   Google Scholar
• Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–381. doi: 10.1016/j.jbi.2008.08.010. PMID:18929686
   PubMed Web of Science ®Google Scholar
• Cook WD, Seiford LM. Priority ranking and consensus formation. Manag Sci. 1978;24:1721–1732. doi: 10.1287/mnsc.24.16.1721.
   Google Scholar
• United States Census Bureau. Quick facts: New Mexico. https://www.census.gov/quickfacts/NM. Published 2015. Accessed June 6, 2016.
   Google Scholar
• United States Census Bureau. Urban and Rural. https://www.census.gov/geo/reference/urban-rural.html. Published 2016. Accessed June 6, 2017.
   Google Scholar
• Kaiser HF. The application of electronic computers to factor analysis. Educ Psychol Meas. 1960;20:141–151. doi: 10.1177/001316446002000116.
   Web of Science ®Google Scholar
• Guttman L. Some necessary conditions for common-factor analysis. Psychometrika. 1954;19:149–161. doi: 10.1007/BF02289162.
   Google Scholar
• SAS statistical software [computer program]. Cary, NC: SAS Institute; 2011.
   Google Scholar
• Stata statistical software [computer program]. College Station, TX: StataCorp; 2015.
   Google Scholar
• Conard LA, Fortenberry JD, Blythe MJ, Orr DP. Pharmacists' attitudes toward and practices with adolescents. Arch Pediatr Adolesc Med. 2003;157:361–365. doi: 10.1001/archpedi.157.4.361. PMID:12695232
   PubMedGoogle Scholar
• Green LW, Kreuter MW. Health Program Planning: An Educational and Ecological Approach. 4th ed. McGraw-Hill Education; 2004.
   Google Scholar
• Binswanger IA, Koester S, Mueller SR, Gardner EM, Goddard K, Glanz JM. Overdose education and naloxone for patients prescribed opioids in primary care: a qualitative study of primary care staff. J Gen Intern Med. 2015;30:1837–1844. doi: 10.1007/s11606-015-3394-3. PMID:26055224
   PubMed Web of Science ®Google Scholar
• Matheson C, Thiruvothiyur M, Robertson H, Bond C. Community pharmacy services for people with drug problems over two decades in Scotland: implications for future development. Int J Drug Policy. 2016;27:105–112. doi: 10.1016/j.drugpo.2015.11.006. PMID:26723885
   PubMed Web of Science ®Google Scholar
• Nielsen S, Menon N, Larney S, Farrell M, Degenhardt L. Community pharmacist knowledge, attitudes and confidence regarding naloxone for overdose reversal. Addiction. 2016;111:2177–2186. doi: 10.1111/add.13517. PMID:27367125
   PubMed Web of Science ®Google Scholar
• Rose VJ, Lutnick A, Kral AH. Feasibility of providing interventions for injection drug users in pharmacy settings: a case study among San Francisco pharmacists. J Psychoactive Drugs. 2014;46:226–232. doi: 10.1080/02791072.2014.921745. PMID:25052881
   PubMed Web of Science ®Google Scholar
• New Mexico Department of Health. Naloxone in New Mexico. https://nmhealth.org/publication/view/marketing/2116/. Published 2016. Accessed October 5, 2017.
   Google Scholar
• American Pharmacists Association. The pursuit of provider status. What pharmacists need to know. http://www.pharmacist.com/sites/default/files/files/Provider%20Status%20FactSheet_Final.pdf. Published 2013. Accessed December 22, 2016.
   Google Scholar
• Hattingh HL, Emmerton L, Ng Cheong Tin P, Green C. Utilization of community pharmacy space to enhance privacy: a qualitative study. Health Expect. 2016;19:1098–1110. doi: 10.1111/hex.12401. PMID:26332335
   PubMed Web of Science ®Google Scholar
• Greenfield BL, Owens MD, Ley D. Opioid use in Albuquerque, New Mexico: a needs assessment of recent changes and treatment availability. Addict Sci Clin Pract. 2014;9:10. doi: 10.1186/1940-0640-9-10. PMID:24942534
   PubMedGoogle Scholar
• US Food and Drug Administration. FDA approves Plan B One-Step emergency contraceptive without a prescription for women 15 years of age and older: April 30, 2013. http://www.fda.gov.libproxy.unm.edu/NewsEvents/Newsroom/PressAnnouncements/ucm350230.htm. Published 2013. Accessed December 22, 2016.
   Google Scholar
• Barton ED, Colwell CB, Wolfe T, et al. Efficacy of intranasal naloxone as a needleless alternative for treatment of opioid overdose in the prehospital setting. J Emerg Med. 2005;29:265–271. doi: 10.1016/j.jemermed.2005.03.007. PMID:16183444
   PubMed Web of Science ®Google Scholar
• Hsu W, Rao RB, Nelson LS. Naloxone hazards overstated. J Toxicol Clin Toxicol. 1997;35: 215–217, 219–220. doi: 10.3109/15563659709001198.
   Web of Science ®Google Scholar
• Wheeler E, Jones TS, Gilbert MK, Davidson PJ. Opioid overdose prevention programs providing naloxone to laypersons—United States, 2014. MMWR Morb Mortal Wkly Rep. 2015;64:631–635.
   PubMed Web of Science ®Google Scholar
• Bazazi AR, Zaller ND, Fu JJ, Rich JD. Preventing opiate overdose deaths: examining objections to take-home naloxone. J Health Care Poor Underserved. 2010;21:1108–1113. PMID:21099064
   PubMed Web of Science ®Google Scholar
• Mitchell KD, Higgins LJ. Combating opioid overdose with public access to naloxone. J Addict Nurs. 2016;27:160–179. doi: 10.1097/JAN.0000000000000132. PMID:27580190
   PubMed Web of Science ®Google Scholar
• Drainoni ML, Koppelman EA, Feldman JA, et al. Why is it so hard to implement change? A qualitative examination of barriers and facilitators to distribution of naloxone for overdose prevention in a safety net environment. BMC Res Notes. 2016;9:465. doi: 10.1186/s13104-016-2268-z. PMID:27756427
   PubMedGoogle Scholar
• Martin SL, Baker RP, Piper BJ. Evaluation of urban-rural differences in pharmacy practice needs in Maine with the MaPPNA. Pharm Pract (Granada). 2015;13:669. doi: 10.18549/PharmPract.2015.04.669. PMID:26759622
   PubMedGoogle Scholar
• Bourgeois B, Marguet P, Gbaguidi-Haore H, et al. Alveolar echinococcosis: how knowledgeable are primary care physicians and pharmacists in the Franche-Comte region of France? Acta Parasitol. 2015;60:682–690. doi: 10.1515/ap-2015-0097. PMID:26408591
   PubMed Web of Science ®Google Scholar
• Wright RE, Reed N, Carnes N, Kooreman HE. Concern about the expanding prescription drug epidemic: a survey of licensed prescribers and dispensers. Pain Physician. 2016;19:E197–E208. PMID:26752487
   PubMed Web of Science ®Google Scholar
• Casserlie LM, Mager NA. Pharmacists' perceptions of advancing public health priorities through medication therapy management. Pharm Pract (Granada). 2016;14:792. doi: 10.18549/PharmPract.2016.03.792.
   PubMedGoogle Scholar
• Roth Y, Neufeld MY, Blatt I, et al. An evaluation of pharmacist knowledge on treatment with antiepileptic drugs. Seizure. 2016;34:60–65. doi: 10.1016/j.seizure.2015.11.007. PMID:26731337
   PubMed Web of Science ®Google Scholar
• Puspitasari HP, Costa DS, Aslani P, Krass I. An explanatory model of community pharmacists' support in the secondary prevention of cardiovascular disease. Res Social Adm Pharm. 2016;12:104–118. doi: 10.1016/j.sapharm.2015.04.008. PMID:26001624
   PubMed Web of Science ®Google Scholar
• Fass JA, Hardigan PC. Attitudes of Florida pharmacists toward implementing a state prescription drug monitoring program for controlled substances. J Manag Care Pharm. 2011;17:430–438. PMID:21787028
   PubMed Web of Science ®Google Scholar
• Schmiedel K, Schlager H, Dorje F. Preventive counselling for public health in pharmacies in South Germany. Int J Clin Pharm. 2013;35:138–144. doi: 10.1007/s11096-012-9722-3. PMID:23129420
   PubMed Web of Science ®Google Scholar
• Cook WD. Distance-based and ad hoc consensus models in ordinal preference ranking. Eur J Oper Res. 2006;172:369–385. doi: 10.1016/j.ejor.2005.03.048.
   Web of Science ®Google Scholar